Gene expression in primary, metastatic and recurrent lesions of endometrial cancer

Gynecologic and Obstetric Investigation

Volumn 48, Issue 3, 1999, Pages 215-220

  Sakamoto, Hideki ^a,b   Kinoshita, Kazuya ^a   Nakayama, Yasuo ^a   Takami, Takeshi ^a   Ohtani, Kaori ^a   Izuka, Sadao ^a   Satoh, Kazuo ^a  

^a NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NIHON UNIVERSITY   (Japan)

Author keywords

Endometrial cancer; Gene expression; Metastasis; Recurrence

Indexed keywords

AUTOCRINE MOTILITY FACTOR; ESTROGEN RECEPTOR; METALLOPROTEINASE; MULTIDRUG RESISTANCE PROTEIN; PROGESTERONE RECEPTOR; RNA; RNA DIRECTED DNA POLYMERASE; TELOMERASE; UVOMORULIN;

ADULT; AGED; CANCER RECURRENCE; CLINICAL ARTICLE; CONFERENCE PAPER; ENDOMETRIUM CANCER; FEMALE; FOLLOW UP; GENE EXPRESSION; GENE REPLICATION; HUMAN; HUMAN CELL; HUMAN TISSUE; METASTASIS; MICROSATELLITE INSTABILITY; ONCOGENE C ERB; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR GROWTH;

ADULT; AGED; CADHERINS; DNA REPLICATION; ENDOMETRIAL NEOPLASMS; FEMALE; GENE EXPRESSION; HUMANS; MATRIX METALLOPROTEINASES; MATRIX METALLOPROTEINASES, MEMBRANE-ASSOCIATED; METALLOENDOPEPTIDASES; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; P-GLYCOPROTEIN; POLYMERASE CHAIN REACTION; RECEPTOR, ERBB-2; RECEPTORS, CYTOKINE; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; TELOMERASE;

EID: 0032878976     PISSN: 03787346     EISSN: None     Source Type: Journal    
DOI: 10.1159/000010159     Document Type: Conference Paper

References (18)

1. Pass HI, Temeck BA: Biology of metastatic disease. Chest Surg Clin N Am 1998;8:1-11.
2. Sood AK, Buller RE: Genomic instability in ovarian cancer: A reassessment using an arbitrarily primed polymerase chain reaction. Oncogene 1996;13:2449-2504.
3. Creasman WT: Prognostic significance of hormone receptors in endometrial cancer. Cancer 1993;71:1467-1470.
4. Firberg LG, Norman H: Prognostic value of steroid hormone receptors for 5-year survival in stage II endometrial cancer. Cancer 1993;71: 3570-3574.
5. Geisler JP, Wiemann MC, Miller GA, Geisler HE: Estrogen and progesterone receptor status as prognostic indicators in patients with optimally cytoreduced stage IIIc serous cystadenocarcinoma of the ovary. Gynecol Oncol 1996; 60:424-427.
6. Baum C, Hegewisch Becker S, Eckert HG, Stocking C, Ostertag W: Novel retroviral vectors for efficient expression of the multidrug resistance (mdr-1) gene in early hematopoietic cells. J Virol 1995;69:7541-7547.
7. Breuninger LM, Paul S, Gaughan K, et al: Expression of multidrug resistance-associated protein in NIH/3T3 cells confers multidrug resistance associated with increased drug efflux and altered intracellular drug distribution. Cancer Res 1995;55:5342-5347.
8. Kavallaris M, Leary JA, Barrett JA, Friedlander ML: MDR1 and multidrug resistance-associated protein (MRP) gene expression in epithelial ovarian tumors. Cancer Lett 1996;102: 7-16.
9. Moran E, Cleary I, Larkin AM, et al: Coexpression of MDR-associated markers, including P-170, MRP and LRP and cytoskeletal proteins, in three resistant variants of the human ovarian carcinoma cell line, OAW42. Eur J Cancer 1997;33:652-660.
10. Sakamoto H, Ohtani K, Takami T, Shirakawa T, Satoh K: A proto-onogene c-erbB-2 coded protein is expressed in metastatic cells of adenocarcinoma of endometrium, cervix and ovaries. Int J Gynecol Cancer 1995;25:411-415.
11. Sato H, Takino T, Okada Y, et al: A matrix metalloproteinase expressed on the surface of invasive tumour cells. Nature 1994;370:61-65.
12. Harada T, Arii S, Mise M, et al: Membrane-type matrix metalloproteinase-1 (MT1-MTP) gene is overexpressed in highly invasive hepatocellular carcinomas. J Hepatol 1998;28:231-239.
13. Sakamoto H, Nakayama Y, Ohtani K, Seiki M, Satoh K: Pulmonary metastatic lesion of endolymphatic stromal myosis expressed metastatis-related genes but no invasion-related matrix type metalloproteinase. Cancer Lett 1997;112: 245-249.
14. Harley CB, Kam NW: Telomerase and cancer. Important Adv Oncol 1996;2:57-67.
15. Hoos A, Hepp HH, Kaul S, Ahlert T, Bastert G, Wallwiender D: Telomerase activity correlates with tumor aggressiveness and reflects therapy effect in breast cancer. Int J Cancer 1998;79: 8-12.
16. Langford, LA, Piatyszek MA, Xu R, Schold SC Jr, Wright WE, Shay JW: Telomerase activity in ordinary meningiomas predicts poor outcome. Hum Pathol 1997;28:416-420.
17. Sulzer MA, Leers MP, van Noord JA, Bollen EC, Theunissen PH: Reduced E-cadherin expression is associated with increased lymph node metastasis and unfavorable prognosis in non-small cell lung cancer. Am J Respir Crit Care Med 1998;157:1319-1323.
18. Caduff RF, Johnston CM, Svoboda Newman SM, Poy EL, Merajver SD, Frank TS: Clinical and pathological significance of microsatellite instability in sporadic endometrial carcinoma. Am J Pathol 1996;148:1671-1678.